A HTS assay for voltage-gated ion channel targets
A HTS assay for voltage-gated ion channel targets
批准号:
6790321
负责人:
Janet Kay Robertson
金额:
$19.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-15 至 2005-08-31
关键词:
bioassaybioengineering /biomedical engineeringbiomedical device power systembiomedical equipment developmentbiotechnologycell linecomputer system design /evaluationconsumable /disposable biomedical equipmentdrug discovery /isolationelectrical measurementelectrical propertyhigh throughput technologyion transportvoltage gated channel
中文摘要
描述(由申请人提供):Membrane Assays, Inc. (MAI)寻求开发和商业化用于电压门控离子通道靶点的高通量筛选(HTS)检测。这种分析被称为离子通道分析(ICA)。ICA利用电场刺激电压门控离子通道。利用荧光技术检测细胞反应。ICA是一种增强型96孔微孔板。在96口井的底面都有微电极。生长在井底的细胞与微电极产生电接触。当在电极之间施加电压时,细胞膜上的局部电势被改变,触发电压门控离子通道的响应。然后可以测量药物阻断、增加或减少这种反应的作用。
英文摘要
DESCRIPTION (provided by applicant): Membrane Assays, Inc. (MAI) seeks to develop and commercialize a high throughput screening (HTS) assay for voltage-gated ion channel targets. The assay is called the Ion Channel Assay (ICA). The ICA uses an electric field to stimulate voltage-gated ion channels. The cellular response is detected optically using fluorescence technology. The ICA is an enhanced 96-well microwell plate. On the bottom surface of each of the 96 wells are microelectrodes. Cells grown on the bottom of the well make electrical contact with the microelectrodes. When a voltage is applied between the electrodes, the local electrical potential across the cellular membrane is altered triggering a response by the voltage-gated ion channels. The action of a pharmaceutical to block, increase or decrease this response can then be measured.
Voltage-gated ion channels play a critical role in such biological processes as the beating of the human heart, the contraction of muscles, and the release of hormones. Therefore, these channels are also important drug targets. No effective manner of rapidly testing the action of a pharmaceutical against a voltage-gated ion channel exists. Traditional patch clamping is too slow and even the new automated patch clamp products, currently in beta testing, do not have the throughput required. The result is missed good drugs. In addition, unknown side-effects of pharmaceuticals on a particular voltage-gated ion channel in the heart, the hERG channel, have led to the removal of 5 drugs from U.S. market. Thus, even if the target molecular of a pharmaceutical is not a voltage-gated ion channel potential new drugs must still be tested against a voltage-gated ion channel, the hERG channel, to uncover side-effects.
MAI proposes to develop a critically needed HTS assay for voltage-gated ion channel targets. The assay is easy to use and compatible with equipment currently in place at most large pharmaceutical companies. Phase I funds will be used to manufacture 100, 96-well plate devices. The fabrication of these first 100 devices will verify the technical feasibility of the proposed manufacturing process and provide plates for ongoing biological testing and assay development. Electrical testing will also be performed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A HTS assay for voltage-gated ion channel targets
-
批准号:7084323
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2004
-
负责人:Janet Kay Robertson
-
依托单位: